Mar 3 2012
A new practice code for pharmaceutical companies now covers all interactions with health care professionals and bans them from giving payments to doctors to attend conferences.
The Wall Street Journal's Corruption Currents blog: Pharma Code Revamp Follows U.S. Industry Sweep
The Geneva-based International Federation of Pharmaceutical Manufacturers and Associations said Thursday it expanded its practice code to cover all interactions with health care professionals, medical institutions and patient organizations, including a ban on doctors from receiving payments to attend conferences (Rubenfeld, 3/1).
In other drug industry news -
MedPage Today: Policies to Spur Clinical Trials in Kids Working, IOM Says
Federal laws aimed at motivating drugmakers to test their medicines in children have yielded important information that has helped doctors give better pediatric care, according to an Institute of Medicine report. However, studies involving children continue to be limited, particularly those in newborns and those analyzing long-term safety and effectiveness of certain drugs in children take as they grow, concluded the IOM panel (Walker, 3/1).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois